Slowing the growth of drug-resistant tumors.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41410553.
- Also identified by DOI 10.7554/eLife.109866 and PMC identifier 12714331.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.
Medical subject headings
- Drug Resistance, Neoplasm
- Breast Neoplasms
- Antineoplastic Agents
- Cell Proliferation
- Protein Kinase Inhibitors